Cure My Disease

Don't miss your cure!

 Log in / Sign up

Centenarians in spain offer clues to living past 100 in good health

NCT ID NCT07707297

Knowledge-focused Sponsor: Fundacion Miguel Servet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study examines people aged 100 and older living in Navarra, Spain, to understand what helps them reach extreme old age with fewer age-related diseases. Researchers will collect medical, cognitive, and lifestyle data along with blood samples to build a detailed picture of healthy aging. The goal is to identify biological and environmental factors that could help others age better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could identify key factors that promote healthy aging and delay age-related diseases, potentially guiding future interventions for longer, healthier lives.
What could go wrong
This is an observational study, not a clinical trial testing a treatment. It may reveal associations but cannot prove what causes longevity, and findings may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 333 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of very old adults aged 100 years and older residing in Navarre, Spain. Participants will be community-dwelling or institutionalized individuals who meet the inclusion criteria and are able to undergo a comprehensive geriatric assessment. The study aims to include a representative sample of the centenarian population in the region.

Ages

100 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals aged ≥100 years * Residents of Navarre, Spain Exclusion Criteria: * Clinical decompensation within the last month, including hemodynamic instability, acute illness, or hospitalization; * End-of-life condition, defined as a clinical state of irreversible deterioration with a life expectancy of days to weeks, as determined by a physician.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Age-related diseases are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Age-related diseases Aging Biomarkers / blood Cellular senescence Frailty

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Navarrabiomed

    RECRUITING

    Pamplona, Navarre, 31001, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.